Current Signal Transduction Therapy

ISSN: 1574-3624 - Volume 3, 3 Issues, 2008

Co-Editors-in-Chief:

György Kéri
Vichem Chemie Research Ltd
1022. Herman O. u. 15
Budapest , Hungary


Axel Ullrich
Department of Molecular Biology
Max Planck Institute
Martinsried
Germany

Editorial Advisory Board:

B.B. Aggarwal (The University of Texas, Houston, TX, USA)
G. Banhegyi (Semmelweis University, Budapest, Hungary)
P.I. Bauer (Semmelweis University, Budapest, Hungary)
L. Buday (Semmelweis University, Budapest, Hungary)
Y. Cao (Karolinska Institute, Stockholm, Sweden)
P. Cohen (University of Dundee, Scotland, UK)
J.E. Crabtree (St. James's University Hospital, Leeds, UK)
P. Czernilofsky (University of Vienna, Vienna, Austria)
M. Daëron (Institut Pasteaur, Paris, France)
S. Damjanovich (University of Debrecen, Debrecen, Hungary)
A. Eberle (University of Basel, Basel, Switzerland)
U. Elben (Clinical Development Vertex Inc., Cambridge, MA, USA)
A. Erdei (Eotvos Science University, Budapest, Hungary)
P.B. Gahan (King’s College London, London, UK)
C. Geula (Harvard Medical School, Boston, MA, USA)
T. Harkany (Karolinska Institute, Stockholm, Sweden)
P. Hirth (Plexxikon Inc., Berkeley, CA, USA)
O. Hobert (Columbia University Medical Centre, New York, NY, USA)
J.A. Houghton (St. Jude Children's Res. Hosp., Memphis, TN, USA)
L.A. Huber (Innsbruck Medical University, Innsbruck, Austria)
T. Hunter (The Salk Institute, San Diego, CA, USA)
M. Karin (University of California, San Diego, CA, USA)
B. Klebl (GPC Biotech AG, Munich, Germany)
E. Klein (Karolinska Institute, Stockholm, Sweden)
A. Levitzki (The Hebrew University of Jerusalem, Jerusalem, Israel)
P.G.M. Luiten (University of Groningen, Groningen, The Netherlands)
H.Q.X. Li (Immusol, Inc., San Diego, CA, USA)
M.V. Magni (Universita degli Studi di Perugia, Perugia, Italy)
S. Meier-Ewert (GPC Biotech AG, Martinsried/Munich, Germany)
G. Molema (University of Groningen, Groningen, The Netherlands)
G. Müller (GPC Biotech AG, Munchen, Germany)
E. Nice (Ludwig Institute for Cancer Research, Parkville, Australia)
R. Nitsch (Charité University Hospital, Berlin, Germany)
Y. Okada (University of Kobe, Kobe, Japan)
L. Örfi (Semmelweis University, Budapest, Hungary)
A. G. Papavassiliou (University of Athens, Athens, Greece)
I. Pecht (The Weizmann Institute of Science, Rehovot, Israel)
B. Penke (Szentgyorgyi University, Szeged, Hungary)
I. Peták (Semmelweis University, Budapest, Hungary)
G. Schmitz (University Hospital Regensburg, Regensburg, Germany)
T. Schulz (Medizinische Hochschule Hannover, Hannover, Germany)
R. Schwab (University of Semmelweis, Budapest, Hungary)
P.H. Seeburg (Max-Planck Inst. for Med. Res., Heidelberg, Germany)
L.K. Shawver (Phenomix Corporation, San Diego, CA, USA)
H.M. Shepard (Receptor BioLogix Inc., San Francisco, CA, USA)
Y. Shimohigashi (Kyushu University, Fukuoka, Japan)
J. Shine (Garvan Institute of Medical Research, Sydney, Australia)
J. Szolcsanyi (Medical University of Pecs, Pecs, Hungary)
M. Vadas (Cryptome, Melbourne, Australia)
J.R. Vandenheede (Katholieke Universiteit Leuven, Leuven, Belgium)
A.F Wilks (Cytopia Ltd., Melbourne, Australia)
P. Workman (Cancer Res. UK Centre for Cancer Therap., Surrey, UK)
Y. Yarden (The Weizmann Institute of Science, Rehovot, Israel)